Clinical Trials for IDH1-Mutated Malignancies

Find clinical trials for idh1-mutated malignancies. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations

NCT ID: NCT07032727

This clinical trial is studying a new combination of medicines to treat certain blood cancers that have come back or did not respond to previous treatment. Specifically, it focuses on patients whos...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

NCT ID: NCT07006688

This clinical trial is studying a new treatment called ivosidenib for adults with certain types of cancers that have a specific genetic mutation known as IDH1. The trial is particularly focused on ...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions